Zaki Mohamed bought ADCT

June 30, 2026 · Form 4 insider transaction

Zaki Mohamed bought 213,900 shares of ADC Therapeutics SA at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
213,900
Price
$0.00
Total value
N/A
Role—
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after896,317
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents an award of restricted stock units ("RSUs") granted on June 30, 2026 pursuant to an incentive award letter agreement. The RSUs will vest upon the earlier of (i) June 30, 2027 or (ii) termination of employment by the Issuer without cause or by the reporting person for good reason, subject to the reporting person's continued employment with the Issuer on the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

View the original Form 4 on SEC EDGAR